Maximus, Inc. ( MMS ) Nowojorska Giełda Papierów Wartościowych

Cena: 70.7 ( 0.97% )

Aktualizacja 06-26 18:34
Nowojorska Giełda Papierów Wartościowych
Branża: Specialty Business Services
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Przemysł
Branża: Specialty Business Services
Zatrudnienie: 39 600
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 99%
Ilość akcji: 61 031 400
Debiut giełdowy: 1997-06-13
WWW: https://www.maximus.com
CEO: Mr. Bruce L. Caswell
Adres: 1600 Tysons Boulevard
Siedziba: 22102 Tysons
ISIN: US5779331041
Opis firmy:

Maximus, Inc. świadczy usługi procesów biznesowych (BPS) rządowym programom zdrowia i usług ludzkich. Działa w trzech segmentach: usługi amerykańskie, usługi federalne w USA, a poza amerykańskim segmentem usług USA oferuje różne rozwiązania BPS, takie jak administracja programu, odwołania i oceny oraz powiązane prace konsultacyjne dla programów państwowych i lokalnych w USA, w tym ustawa o niedrogiej opiece, Medicaid, program ubezpieczenia zdrowotnego dzieci, tymczasowa pomoc dla potrzeb potrzebnych, programów alimentacyjnych, preadMission Scections oraz recenzji, oraz oceny niezależnych rozwoju. Ten segment zapewnia również wsparcie i rejestrację kwalifikowalności w programie; Scentralizowane wielojęzyczne centra kontaktowe klienta, wielokanałowe i cyfrowe opcje samoobsługowe do rejestracji; pomoc aplikacyjna i niezależne porady dotyczące wyboru planu zdrowotnego; Beneficjent, edukacja, kwalifikowanie, rejestracja i ponowne określenie; Niezależna niepełnosprawność, długoterminowa choroba i inne oceny zdrowia; oraz specjalistyczne usługi konsultacyjne. Segment usług federalnych USA oferuje scentralizowane centra zaangażowania obywateli i usługi wsparcia; Zarządzanie dokumentami i rekordami; Zarządzanie sprawami, wsparcie obywateli i edukacja konsumencka; Niezależne recenzje medyczne i odwołania od wynagrodzeń pracowników; Apele Medicare i Medicaid; oraz odwołania do kwalifikowalności na rynku federalnym. Ten segment zapewnia również modernizację infrastruktury systemów i technologii informatycznych; Operacje infrastrukturalne i usługi wsparcia; Opracowywanie oprogramowania, operacje i zarządzanie; oraz usługi analizy danych. Segment zewnętrzny amerykański oferuje rozwiązania BPS dla rządów i klientów komercyjnych poza Stanami Zjednoczonymi, w tym oceny zdrowia i niepełnosprawności, administrację programu w zakresie usług zatrudnienia oraz inne usługi związane z pracownikami. Firma została zarejestrowana w 1975 roku i ma siedzibę w Tysons w stanie Wirginia.

Wskaźniki finansowe
Kapitalizacja (USD) 3 983 902 580
Aktywa: 4 131 508 000
Cena: 70.7
Wskaźnik Altman Z-Score: 3.4
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 1
P/E: 14.2
Ilość akcji w obrocie: 99%
Średni wolumen: 467 161
Ilość akcji 56 349 400
Wskaźniki finansowe
Przychody TTM 5 306 197 000
Zobowiązania: 2 288 693 000
Przedział 52 tyg.: 63.77 - 93.97
Piotroski F-Score: 8
Silny (dobra jakość finansowa)
EPS: 5.0
P/E branży: 18.4
Beta: 0.768
Raport okresowy: 2025-08-05
WWW: https://www.maximus.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David W. Mutryn Chief Financial Officer & Treasurer 861 270 1982
Ms. Ilene R. Baylinson General Manager of Health Services U.S. 851 264 1958
Mr. Bruce L. Caswell President, Chief Executive Officer & Director 1 761 189 1967
Ms. Elisabeth Schmidt Senior Vice President of Technology & Consulting Services 0 0
Ms. Julia Bailey Senior Vice President of Global Ethics & Compliance 0 0
Ms. Theresa D. Golinvaux Principal Accounting Officer, Senior Vice President & Corporate Controller 0 1975
Mr. Derrick Pledger Chief Digital & Information Officer (CDIO) 0 0
Mr. John T. Martinez General Counsel, Chief Legal Officer & Corporate Secretary 0 1973
Mr. Jericho Seguin Senior Vice President of Corporate Development & Strategic Planning 0 0
Ms. Eileen Cassidy Rivera Vice President of Communications & Public Relations 0 0
Wiadomości dla Maximus, Inc.
Tytuł Treść Źródło Aktualizacja Link
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-05-16 14:45:44 Czytaj oryginał (ang.)
Best Income Stocks to Buy for May 12th SUZ, ADRNY and MMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 12, 2025. zacks.com 2025-05-12 15:36:04 Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q2 2025 Earnings Call Transcript Maximus, Inc. (NYSE:MMS ) Q2 2025 Results Conference Call May 8, 2025 9:00 AM ET Company Participants Jessica Batt - Vice President of Investor Relations and ESG Bruce Caswell - President and Chief Executive Officer David Mutryn - Chief Financial Officer and Treasurer Conference Call Participants Charles Strauzer - CJS Securities Operator Greetings, and welcome to the Maximus Fiscal 2025 Second Quarter Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com 2025-05-10 13:46:04 Czytaj oryginał (ang.)
Maximus' Q2 Earnings & Revenues Beat Estimates, Increase Y/Y MMS' second-quarter fiscal 2025 earnings and revenues increased year over year. zacks.com 2025-05-09 16:50:36 Czytaj oryginał (ang.)
Maximus (MMS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-05-08 14:35:57 Czytaj oryginał (ang.)
Maximus (MMS) Q2 Earnings and Revenues Surpass Estimates Maximus (MMS) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.57 per share a year ago. zacks.com 2025-05-08 12:50:42 Czytaj oryginał (ang.)
Maximus Reports Fiscal Year 2025 Second Quarter Results TYSONS, Va.--(BUSINESS WIRE)--Maximus reports financial results for the three and six months ending March 31, 2025. businesswire.com 2025-05-08 10:30:00 Czytaj oryginał (ang.)
Gear Up for Maximus (MMS) Q2 Earnings: Wall Street Estimates for Key Metrics Evaluate the expected performance of Maximus (MMS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2025-05-07 14:21:32 Czytaj oryginał (ang.)
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS) Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product globenewswire.com 2025-05-05 12:30:00 Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-04-24 14:45:47 Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now MMS maintains solid relationships and a strong reputation with governments. zacks.com 2025-04-11 16:20:37 Czytaj oryginał (ang.)
Maximus (MMS) Upgraded to Strong Buy: What Does It Mean for the Stock? Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com 2025-04-10 17:01:14 Czytaj oryginał (ang.)
Maximus Schedules Fiscal 2025 Second Quarter Conference Call TYSONS, Va.--(BUSINESS WIRE)--Maximus schedules its second quarter earnings call for FY25 for Thursday, May 8, and will issue a release with its financial results that morning. businesswire.com 2025-04-10 13:00:00 Czytaj oryginał (ang.)
Buy the Dip in These Highly Ranked Stocks Near 52-Week Lows: MMS, RNG Government program operator Maximus (MMS) and internet software services provider RingCentral (RNG) are two stocks that have become increasingly intriguing near their 52-week lows. zacks.com 2025-04-08 18:55:29 Czytaj oryginał (ang.)
Maximus Benefits From Buyouts & Strong Cash Flow From Operations The MMS stock is improving on the back of a strong operating cash flow, providing it with a competitive edge. zacks.com 2025-04-03 16:40:51 Czytaj oryginał (ang.)
Is Maximus (MMS) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-03-31 14:41:17 Czytaj oryginał (ang.)
Maximus Total Experience Management (TXM) Adds Salesforce's Agentforce to Transform Customer Experience for Government TYSONS, Va.--(BUSINESS WIRE)--Maximus announces new technology partnership with Salesforce. businesswire.com 2025-03-24 13:00:00 Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-03-13 12:46:14 Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now MMS maintains solid relationships and a strong reputation with governments. zacks.com 2025-03-10 15:35:18 Czytaj oryginał (ang.)
Maximus (MMS) Upgraded to Strong Buy: Here's Why Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com 2025-03-04 15:05:34 Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-02-25 12:40:35 Czytaj oryginał (ang.)
Maximus' Q1 Earnings & Revenues Beat Estimates, Increase Y/Y MMS' first-quarter fiscal 2025 revenues and earnings rise 20.2% and 5.7% on a year-over-year basis. zacks.com 2025-02-14 11:26:17 Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q1 2025 Earnings Call Transcript Maximus, Inc. (NYSE:MMS ) Q1 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Jessica Batt - Vice President of Investor Relations and ESG Bruce Caswell - President and Chief Executive Officer David Mutryn - Chief Financial Officer and Treasurer Conference Call Participants Charlie Strauzer - CJS Securities Brian Gesuale - Raymond James Operator Greetings and welcome to the Maximus Fiscal 2025 First Quarter Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com 2025-02-06 15:02:20 Czytaj oryginał (ang.)
Maximus (MMS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-02-06 12:36:24 Czytaj oryginał (ang.)
Maximus (MMS) Q1 Earnings and Revenues Top Estimates Maximus (MMS) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.34 per share a year ago. zacks.com 2025-02-06 10:41:12 Czytaj oryginał (ang.)
Maximus Reports Fiscal Year 2025 First Quarter Results TYSONS, Va.--(BUSINESS WIRE)--Maximus reports financial results for the three months ending December 31, 2024. businesswire.com 2025-02-06 08:30:00 Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-02-04 12:45:42 Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-01-16 12:45:27 Czytaj oryginał (ang.)
Best Value Stocks to Buy for January 13th GBX, FHN and MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 13, 2025. zacks.com 2025-01-13 13:50:20 Czytaj oryginał (ang.)
Maximus Schedules Fiscal 2025 First Quarter Conference Call TYSONS, Va.--(BUSINESS WIRE)--Maximus schedules its first quarter earnings call for FY25 for Thursday, February 6, and will issue a release with its financial results that morning. businesswire.com 2025-01-09 11:00:00 Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now MMS maintains solid relationships and a strong reputation with governments. zacks.com 2025-01-07 16:31:33 Czytaj oryginał (ang.)
Maximus Wins Contracts to Continue Medical Disability Exam Services for Veterans TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading employer and provider of government services, today announced that VES, a Maximus Company, was re-awarded contracts for domestic Regions 1 through 4, collectively spanning the continental U.S., to continue providing Medical Disability Exam (MDE) services on behalf of the VBA. The cumulative value of the award to VES more than accommodates current and anticipated production volumes over the contract term and each of the four regional c. businesswire.com 2025-01-06 10:00:00 Czytaj oryginał (ang.)
Maximus Declares Quarterly Cash Dividend of $0.30 Per Share TYSONS, Va.--(BUSINESS WIRE)--Maximus announces a quarterly cash dividend of $0.30 per share, payable on February 28, 2025, to shareholders of record on February 15, 2025. businesswire.com 2025-01-06 08:30:00 Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-12-31 13:01:32 Czytaj oryginał (ang.)
Is Maximus (MMS) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-12-12 12:41:11 Czytaj oryginał (ang.)
Maximus (MMS) Loses -21.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Maximus (MMS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com 2024-12-11 12:35:54 Czytaj oryginał (ang.)
Maximus Completes Divestiture of Australia and South Korea in Outside the U.S. Segment TYSONS, Va.--(BUSINESS WIRE)--Maximus divests all operations in Australia and South Korea, which were reported under the Outside the U.S. segment, to Angus Knight. businesswire.com 2024-12-10 10:00:00 Czytaj oryginał (ang.)
Here's Why Maximus Stock is a Great Pick for You Right Now MMS stock is benefiting from business process expansion on the back of strategic buyouts. Consistent dividend payments boost investor confidence. zacks.com 2024-12-06 12:41:29 Czytaj oryginał (ang.)
Maximus Earns URAC Accreditation for Health Utilization Management in Clinical Reviews TYSONS, Va.--(BUSINESS WIRE)--Maximus has again earned URAC full accreditation for Health Utilization Management for clinical reviews. businesswire.com 2024-12-04 12:00:00 Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-26 12:40:57 Czytaj oryginał (ang.)
Down -16.15% in 4 Weeks, Here's Why Maximus (MMS) Looks Ripe for a Turnaround Maximus (MMS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com 2024-11-25 12:35:14 Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q4 2024 Earnings Call Transcript Maximus, Inc. (NYSE:MMS ) Q4 2024 Earnings Call Transcript November 21, 2024 9:00 AM ET Company Participants Jessica Batt - VP of IR and ESG Bruce Caswell - President and CEO David Mutryn - CFO Conference Call Participants Charlie Strauzer - CJS Securities Operator Greetings, and welcome to the Maximus Fiscal 2024 Fourth Quarter and Year End Earnings Conference Call. At this time, all participants are on a listen-only mode. seekingalpha.com 2024-11-21 18:12:44 Czytaj oryginał (ang.)
Maximus' Q4 Revenues Surpass Estimates, Earnings Miss Maximus' fourth-quarter fiscal 2024 earnings and revenues increase on a year-over-year basis. zacks.com 2024-11-21 11:30:34 Czytaj oryginał (ang.)
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Thursday. benzinga.com 2024-11-21 09:28:31 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Maximus (MMS) Q4 Earnings The headline numbers for Maximus (MMS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-11-20 21:00:30 Czytaj oryginał (ang.)
Maximus (MMS) Lags Q4 Earnings Estimates Maximus (MMS) came out with quarterly earnings of $1.46 per share, missing the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.29 per share a year ago. zacks.com 2024-11-20 20:16:37 Czytaj oryginał (ang.)
Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2024 TYSONS, Va.--(BUSINESS WIRE)--Maximus announces its fourth quarter and year-end results for fiscal year 2024. businesswire.com 2024-11-20 18:05:00 Czytaj oryginał (ang.)
Curious about Maximus (MMS) Q4 Performance? Explore Wall Street Estimates for Key Metrics Get a deeper insight into the potential performance of Maximus (MMS) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2024-11-15 12:21:31 Czytaj oryginał (ang.)
Best Value Stocks to Buy for October 17th NEXN, HRB and MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 17, 2024. zacks.com 2024-10-17 11:05:26 Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-10-15 14:45:50 Czytaj oryginał (ang.)
New Strong Buy Stocks for October 11th AGESY, INTA, STEP, CURV and MMS have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2024. zacks.com 2024-10-11 08:16:09 Czytaj oryginał (ang.)
Maximus Stock Ascends 11% in Six Months: Buy, Hold or Sell? MMS exhibits strong long-term growth potential, making it a stock worth monitoring for an ideal investment opportunity. zacks.com 2024-09-26 16:25:19 Czytaj oryginał (ang.)
Efficient Receivables Management Aids Maximus Amid Declining Income Expertise in business process management and the ability to deliver efficient and cost-effective solutions make MMS a lucrative choice for governments. zacks.com 2024-09-18 13:56:21 Czytaj oryginał (ang.)